Trials / Completed
CompletedNCT00778154
Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate
A Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Long-Term Alendronate or Risedronate
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 105 (actual)
- Sponsor
- Warner Chilcott · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Patients who have received the appropriate number of years of alendronate or risedronate therapy will be recruited. Each patient will have received baseline BMD measurements performed at the spine and the hip by DXA. Each patient will receive tetracycline to label the bone and then have a transiliac bone biopsy. One year later teh bone label and biopsy procedure will be repeated.
Conditions
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2006-12-01
- Completion
- 2006-12-01
- First posted
- 2008-10-23
- Last updated
- 2013-06-05
Locations
8 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00778154. Inclusion in this directory is not an endorsement.